Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. — ME/CFS Atlas
Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells.
Amel Kashipaz, M R, Swinden, D, Todd, I et al. · Clinical and experimental immunology · 2003 · DOI
Quick Summary
Researchers tested whether immune system cells from ME/CFS and fibromyalgia patients produce abnormal levels of inflammatory chemicals called cytokines. Using advanced microscopy techniques to examine individual immune cells, they found that cytokine production was normal in patients compared to healthy controls. This suggests that abnormal cytokine production may not be the main cause of these conditions.
Why It Matters
This study addresses conflicting findings in the literature about immune dysfunction in ME/CFS by using a more precise single-cell technique (flow cytometry) rather than aggregate measurement methods. Understanding whether cytokine abnormalities drive ME/CFS symptoms is crucial for identifying targeted treatments and distinguishing ME/CFS from other inflammatory conditions.
Observed Findings
Mean intensity of fluorescence and percentage of IL-1α, IL-6, TNF-α, and IL-10 producing CD14+ monocytes were comparable between ME/CFS/fibromyalgia patients and sex- and age-matched controls.
CD14- lymphocyte cytokine production was similarly comparable between patients and controls.
Results were consistent in both unstimulated and IFN-γ-stimulated culture conditions.
Findings remained consistent after polymyxin B treatment to eliminate endotoxin effects on monocyte activation.
Inferred Conclusions
Dysregulation of inflammatory and anti-inflammatory cytokine production by circulating monocytes and lymphocytes is not a dominant factor in ME/CFS and fibromyalgia pathogenesis.
The conflicting cytokine findings reported in previous studies using ELISA or PCR may reflect methodological differences rather than true biological abnormalities.
Abnormalities in ME/CFS/FMS, if immune-mediated, likely involve mechanisms other than altered cytokine production by blood mononuclear cells.
Remaining Questions
Why do other studies using different detection methods (ELISA, PCR) report cytokine abnormalities if flow cytometry shows normal levels?
Might ME/CFS involve cytokine dysregulation in tissues or specific immune cell subsets not captured by this peripheral blood analysis?
What This Study Does Not Prove
This study does not prove that immune dysfunction plays no role in ME/CFS—it only suggests cytokine dysregulation is not a dominant factor in this specific pathway. It also does not exclude abnormalities in other immune mechanisms (T-cell function, complement activation, viral reactivation) or other biological systems. The findings reflect cytokine production at a single time point and may not capture dynamic changes throughout illness or in response to post-exertional malaise.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.